Pharmacology of intracellular cytosine-arabinoside-5′-triphosphate in malignant cells of pediatric patients with initial or relapsed leukemia and in normal lymphocytes U. KoehlG. HollatzD. Schwabe Original Article 14 December 2006 Pages: 467 - 477
A phase I pharmacodynamic study of the effects of the cyclin-dependent kinase-inhibitor AZD5438 on cell cycle markers within the buccal mucosa, plucked scalp hairs and peripheral blood mononucleocytes of healthy male volunteers D. Ross CamidgeMike PembertonAndrew Hughes Original Article 02 December 2006 Pages: 479 - 488
A phase II trial of gemcitabine plus capecitabine for patients with advanced pancreatic adenocarcinoma Byeong-Bae ParkJoon Oh ParkKeunchil Park Original Article 30 March 2007 Pages: 489 - 494
Phase II trial of gemcitabine and docetaxel in patients with completely resected stage IIA–IIIA non-small-cell lung cancer Masafumi KawamuraKeisuke EguchiKoichi Kobayashi Original Article 02 December 2006 Pages: 495 - 501
DPYD*2A mutation: the most common mutation associated with DPD deficiency M. W. SaifHany EzzeldinRobert B. Diasio Original Article 13 December 2006 Pages: 503 - 507
Long-term effects of 7-monohydroxyethylrutoside (monoHER) on DOX-induced cardiotoxicity in mice Anna M. E. BruynzeelSuzanne Vormer-BonneWim J. F. van der Vijgh Original Article 20 December 2006 Pages: 509 - 514
Genetic linkage of UGT1A7 and UGT1A9 polymorphisms to UGT1A1*6 is associated with reduced activity for SN-38 in Japanese patients with cancer Ken-ichi FujitaYuichi AndoYasutsuna Sasaki Original Article 04 April 2007 Pages: 515 - 522
Phase I and pharmacokinetic trial of AP5346, a DACH–platinum–polymer conjugate, administered weekly for three out of every 4 weeks to advanced solid tumor patients Mario CamponeJeany M. Rademaker-LakhaiJan H. M. Schellens Original Article 17 February 2007 Pages: 523 - 533
Targeting c-Src kinase enhances tamoxifen’s inhibitory effect on cell growth by modulating expression of cell cycle and survival proteins Maricarmen D. Planas-SilvaKecia N. Hamilton Original Article 21 December 2006 Pages: 535 - 543
R-etodolac (SDX-101) and the related indole–pyran analogues SDX-308 and SDX-309 potentiate the antileukemic activity of standard cytotoxic agents in primary chronic lymphocytic leukaemia cells Elin LindhagenSara NissleAnna Åleskog Original Article 22 December 2006 Pages: 545 - 553
Effect of a V-ATPase inhibitor, FR202126, in syngeneic mouse model of experimental bone metastasis Kazuaki Niikura Original Article 23 December 2006 Pages: 555 - 562
Plasma and cerebrospinal fluid pharmacokinetics of intravenously administered ABT-751 in non-human primates Steve Y. ChoElizabeth FoxFrank M. Balis Original Article 23 December 2006 Pages: 563 - 567
Influence of ketoconazole on the fecal and urinary disposition of docetaxel Frederike K. EngelsWalter J. LoosJaap Verweij Original Article Open access 26 January 2007 Pages: 569 - 579
Trichosanthin down-regulated p210Bcr-Abl and enhanced imatinib-induced growth arrest in chronic myelogenous leukemia cell line K562 Kunzhong ZhangJianhua XuZhiqiang Zhang Original Article 14 April 2007 Pages: 581 - 587
Preclinical antitumor activity of the oral platinum analog satraplatin Katja WosikowskiLou LamphereMaureen Caligiuri Original Article 31 May 2007 Pages: 589 - 600
Phase II study of gemcitabine and carboplatin in patients with advanced non-small-cell lung cancer Lin Run WangMing Zhu HuangXiu Hua Wu Original Article 05 June 2007 Pages: 601 - 607
A limited sampling strategy to estimate individual pharmacokinetic parameters of methotrexate in children with acute lymphoblastic leukemia Christine PiardFrançoise BressolleEvelyne Jacqz-Aigrain Original Article 29 December 2006 Pages: 609 - 620
A limited sampling strategy to estimate individual pharmacokinetic parameters of methotrexate in children with acute lymphoblastic leukemia Christine PlardFrançoise BressolleEvelyne Jacqz-Aigrain Erratum 04 July 2007 Pages: 621 - 621
Is rectal administration an alternative route for imatinib? Nielka P. H. van ErpRoos L. OostendorpHans Gelderblom Short Communication Open access 08 February 2007 Pages: 623 - 624
